The molecular structure of complexes formed by chromium or cobalt ions in simulated physiological fluids

Biomaterials

Volumn 30, Issue 4, 2009, Pages 460-467

  Tkaczyk, Cathy ^a   Huk, Olga L ^a,b   Mwale, Fackson ^b   Antoniou, John ^a,b   Zukor, David J ^b   Petit, Alain ^b   Tabrizian, Maryam ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Chromium; Cobalt; Molecular interactions; Nanoscale complexes; Simulated physiological fluids; Toxicity

Indexed keywords

AMINATION; AMINES; AMINO ACIDS; CALCIUM; CHELATION; CHEMICAL ANALYSIS; CHROMIUM; COBALT; ELECTROLYSIS; FOURIER TRANSFORMS; GLUCOSE; HYDROGEN; HYDROGEN BONDS; INFRARED SPECTROSCOPY; IONS; METAL ANALYSIS; METAL IONS; MICROSCOPIC EXAMINATION; MOLECULAR STRUCTURE; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; OCCUPATIONAL RISKS; ORGANIC ACIDS; PHOTORESISTS; QUANTUM CHEMISTRY; SULFUR; TOXICITY; TRACE ANALYSIS; TRANSITION METALS; VEGETATION;

BIOLOGICAL ENVIRONMENTS; BIOLOGICAL FLUIDS; CANCER.; CHEMICAL COMPLEXES; CHEMICAL FORMS; COBALT IONS; CR COMPLEXES; ELEMENTAL ANALYSES; FOURIER TRANSFORM INFRARED; HARD METALS; HIGH GLUCOSE MEDIAS; HIGH GLUCOSES; IN VITRO; IN-VIVO; LIVING ORGANISMS; LOW ENERGIES; NANOSCALE; NANOSCALE COMPLEXES; NO COMPLEXES; PHYSIOLOGICAL FLUIDS; RAY ANALYSES; SIMULATED PHYSIOLOGICAL FLUIDS; TRANSMISSION ELECTRON MICROSCOPY OBSERVATIONS;

CHROMIUM COMPOUNDS;

AMINO ACID; CALCIUM; CHROMIUM DERIVATIVE; COBALT COMPLEX; CYSTINE; METHIONINE; PHOSPHATE; SULFUR;

ARTICLE; BODY FLUID; CHELATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; PRECIPITATION; PRIORITY JOURNAL; SIMULATION; TRANSMISSION ELECTRON MICROSCOPY; X RAY ANALYSIS;

BODY FLUIDS; CHROMIUM; COBALT; CULTURE MEDIA; ELEMENTS; IONS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 56449108257     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.09.055     Document Type: Article

References (40)

1. Brockett C., Williams S., Jin Z., Isaac G., and Fisher J. Friction of total hip replacements with different bearings and loading conditions. J Biomed Mater Res Part B Appl Biomater 81B (2007) 508-515
2. Sargeant A., and Goswami T. Pathophysiological aspects of hip implants. J Surg Orthop Adv 15 (2006) 111-112
3. Ren W.P., Markel D.C., Zhang R., Peng X., Wu B., Monica H., et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 30 (2006) 5161-5169
4. Geller J.A., Malchau H., Bragdon C., Greene M., Harris W.H., and Freiberg A.A. Large diameter femoral heads on highly cross-linked polyethylene: minimum 3-year results. Clin Orthop Relat Res 447 (2006) 53-59
5. Sharkey P.F., Hozack W.J., Dorr L.D., Maloney W.J., and Berry D. The bearing surface in total hip arthroplasty: evolution or revolution. Instr Course Lect 49 (2000) 41-56
6. Williams S., Tipper J.L., Ingham E., Stone M.H., and Fisher J. In vitro analysis of the wear, wear debris and biological activity of surface-engineered coatings for use in metal-on-metal total hip replacements. Proc Inst Mech Eng [H] 217 (2003) 155-163
7. Jacobs J.J., Skipor A.K., Patterson L.M., Hallab N.J., Paprosky W.G., Black J., et al. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am 80B (1998) 1447-1458
8. Jacobs J.J., Skipor A.K., Doorn P.F., Campbell P., Schmalzried T.P., Black J., et al. Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop Relat Res 329 Suppl. (1996) S256-S263
9. IARC. Chromium, nickel and welding. Monogr Eval Carcinog Risks Hum 49 (1990) 1-648
10. Langkamer V.G., Case C.P., Heap P., Taylor A., Collins C., Pearse M., et al. Systemic distribution of wear debris after hip replacement. A cause for concern?. J Bone Joint Surg Br 74B (1992) 831-839
11. Merritt K., and Brown S.A. Distribution of cobalt chromium wear and corrosion products and biologic reactions. Clin Orthop Relat Res 329 Suppl. (1996) S233-S243
12. Zhitkovich A., Peterson-Roth E., and Reynolds M. Killing of chromium-damaged cells by mismatch repair and its relevance to carcinogenesis. Cell Cycle 8 (2005) 1050-1052
13. Levina A., Harris H.H., and Lay P.A. Binding of chromium(VI) to histones: implications for chromium(VI)-induced genotoxicity. J Biol Inorg Chem 11 (2006) 225-234
14. Moghaddas S., Gelerinter E., and Bose R.N. Mechanisms of formation and decomposition of hypervalent chromium metabolites in the glutathione-chromium(VI) reaction. J Inorg Biochem 57 (1995) 135-146
15. Stearns D.M., Kennedy L.J., Courtney K.D., Giangrande P.H., Phieffer L.S., and Wetterhahn K.E. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 34 (1995) 910-919
16. Gez S., Luxenhofer R., Levina A., Codd R., and Lay P.A. Chromium(V) complexes of hydroxamic acids: formation, structures, and reactivities. Inorg Chem 44 (2005) 2934-2943
17. Voitkun V., Zhitkovich A., and Costa M. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res 6 (1998) 2024-2030
18. Cobb A.G., and Schmalzreid T.P. The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty. Proc Inst Mech Eng [H] 220 (2006) 385-398
19. Catelas I., Petit A., Vali H., Fragiskatos C., Meilleur R., Zukor D.J., et al. Quantitative analysis of macrophage apoptosis vs. necrosis induced by cobalt and chromium ions in vitro. Biomaterials 26 (2005) 2441-2453
20. Fleury C., Petit A., Mwale F., Antoniou J., Zukor D.J., Tabrizian M., et al. Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: morphology, cytotoxicity, and oxidative stress. Biomaterials 27 (2006) 3351-3360
21. Petit A., Mwale F., Tkaczyk C., Antoniou J., Zukor D.J., and Huk O.L. Induction of protein oxidation by cobalt and chromium ions in human U937 macrophages. Biomaterials 26 (2005) 4416-4422
22. Petit A., Mwale F., Tkaczyk C., Antoniou J., Zukor D.J., and Huk O.L. Cobalt and chromium ions induce nitration of proteins in human U937 macrophages in vitro. J Biomed Mater Res Part A 79A (2006) 599-605
23. Salnikow K., Su W., Blagosklonny M.V., and Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res 60 (2000) 3375-3378
24. Kitahara J., Yamanaka K., Kato K., Lee Y.W., Klein C.B., and Costa M. Mutagenicity of cobalt and reactive oxygen producers. Mutat Res 370 (1996) 133-140
25. Zhitkovich A., Voitkun V., and Costa M. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry 35 (1996) 7275-7282
26. Case C.P., Langkamer V.G., James C., Palmer M.R., Kemp A.J., Heap P.F., et al. Widespread dissemination of metal debris from implants. J Bone Joint Surg Br 76B (1994) 701-712
27. Chaudhary S., Pinkston J., Rabile M.M., and Van Horn J.D. Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes. J Inorg Biochem 99 (2005) 787-794
28. Messer J., Reynolds M., Stoddard L., and Zhitkovich A. Causes of DNA single-strand breaks during reduction of chromate by glutathione in vitro and in cells. Free Radic Biol Med 40 (2006) 1981-1992
29. Walter P.B., Macklin E.A., Porter J., Evans P., Kwiatkowski J.L., Neufeld E.J., et al. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica 93 (2008) 817-823
30. Cai L., Li X.K., Song Y., and Cherian M.G. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem 12 (2005) 2753-2763
31. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., and Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180 (2002) 5-22
32. Bagchi D., Bagchi M., and Stohs S.J. Chromium(VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Mol Cell Biochem 222 (2001) 149-158
33. Blasiak J., and Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat Res 469 (2000) 135-145
34. Shelnutt S.R., Goad P., and Belsito D.V. Dermatological toxicity of hexavalent chromium. Crit Rev Toxicol 37 (2007) 375-387
35. Nethercott J., Paustenbach D., Adams R., Fowler J., Marks J., Morton C., et al. A study of chromium induced allergic contact dermatitis with 54 volunteers: implications for environmental risk assessment. Occup Environ Med 51 (1994) 371-380
36. Goulart M., Batoréu M.C., Rodrigues A.S., Laires A., and Rueff J. Lipoperoxidation products and thiol antioxidants in chromium exposed workers. Mutagenesis 20 (2005) 311-315
37. Sipowicz M.A., Anderson L.M., Utermahlen Jr. W.E., Issaq H.J., and Kasprzak K.S. Uptake and tissue distribution of chromium(III) in mice after a single intraperitoneal or subcutaneous administration. Toxicol Lett 93 (1997) 9-14
38. Suzuki T., Miyata N., Horitsu H., Kawai K., Takamizawa K., Tai Y., et al. NAD(P)H-dependent chromium(VI) reductase of Pseudomonas ambigua G-1: a Cr(V) intermediate is formed during the reduction of Cr(VI) to Cr(III). J Bacteriol 174 (1992) 5340-5345
39. Buttner B., and Beyersmann D. Modification of the erythrocyte anion carrier by chromate. Xenobiotica 15 (1985) 735-741
40. Biedermann K.A., and Landolph J.R. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res 50 (1990) 7835-7842